The increasing demand for controlled immunological study and therapeutic creation has spurred significant improvements in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using multiple expression platforms, including prokaryotic hosts, higher cell cultures, and